跳至主要内容
临床试验/RBR-6pmfz8
RBR-6pmfz8招募中3 期

Acute Lymphoblastic Leukemia treatment protocol for children and adolescent GBTLI ALL-2009 - GBTLI ALL-2009: GBTLI ALL-2009

Sociedade Brasileira de Oncologia Pediátrica (SOBOPE)0 个研究点开始时间: 2016年3月11日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
0D 至 18Y(—)

入选标准

  • Will be eligible for this study all patients aged < 18 years (up to 17.99 years ) diagnosed with previously untreated ALL, with emphasis on no steroid use.
  • The requisites for proper leukemia diagnostic profile are: cytomorphological analysis, cytochemistry, immunephenotyping spinal fluid profile, cytogenetics and molecular biology
  • All patients and their legal representatives should be informed about the investigative nature of this study and must sign and provide free and informed consent in accordance with institutional and federal recommendations.

排除标准

  • Without Informed Consent Term.
  • ALL patient aged > 18 years.
  • Prior use of corticosteroids.
  • Not confirmed the ALL diagnosis, after Central review.

研究者

发起方
Sociedade Brasileira de Oncologia Pediátrica (SOBOPE)

相似试验